261 related articles for article (PubMed ID: 20226250)
1. The seroepidemiology of Bordetella pertussis in Israel--Estimate of incidence of infection.
Rendi-Wagner P; Tobias J; Moerman L; Goren S; Bassal R; Green M; Cohen D
Vaccine; 2010 Apr; 28(19):3285-90. PubMed ID: 20226250
[TBL] [Abstract][Full Text] [Related]
2. The utility of seroepidemiology for tracking trends in pertussis infection.
Quinn HE; McIntyre PB; Backhouse JL; Gidding HF; Brotherton J; Gilbert GL
Epidemiol Infect; 2010 Mar; 138(3):426-33. PubMed ID: 19719902
[TBL] [Abstract][Full Text] [Related]
3. Seroprevalence of Bordetella pertussis antibody in children and adolescents in China.
Wang CQ; Zhu QR
Pediatr Infect Dis J; 2011 Jul; 30(7):593-6. PubMed ID: 21422963
[TBL] [Abstract][Full Text] [Related]
4. The incidence of Bordetella pertussis infections estimated in the population from a combination of serological surveys.
de Melker HE; Versteegh FG; Schellekens JF; Teunis PF; Kretzschmar M
J Infect; 2006 Aug; 53(2):106-13. PubMed ID: 16352342
[TBL] [Abstract][Full Text] [Related]
5. Population-based incidence of pertussis among adolescents and adults, Minnesota, 1995-1996.
Strebel P; Nordin J; Edwards K; Hunt J; Besser J; Burns S; Amundson G; Baughman A; Wattigney W
J Infect Dis; 2001 May; 183(9):1353-9. PubMed ID: 11294666
[TBL] [Abstract][Full Text] [Related]
6. Incidence of pertussis in persons < or =15 years of age in Valencia, Spain: seroprevalence of antibodies to pertussis toxin (PT) in children, adolescents and adults.
Diez-Domingo J; Ballester A; Baldó JM; Planelles MV; Villarroya JV; Alvarez T; Carmen Peidró M; Calero P; Garcés MD; Sorribes I; Graullera M; Jubert A; San-Martín M; González A
J Infect; 2004 Oct; 49(3):242-7. PubMed ID: 15337342
[TBL] [Abstract][Full Text] [Related]
7. Seroprevalence of IgG antibodies against Bordetella pertussis in healthy individuals aged 4-24 years in Turkey.
Cevik M; Beyazova U; Aral AL; Duyan Camurdan A; Ozkan S; Sahin F; Aybay C
Clin Microbiol Infect; 2008 Apr; 14(4):388-90. PubMed ID: 18190581
[TBL] [Abstract][Full Text] [Related]
8. Seroprevalence of Bordetella pertussis infection during pregnancy measured by IgG antibodies against pertussis toxin.
Nooitgedagt JE; de Greeff SC; Elvers BH; de Melker HE; Notermans DW; van Huisseling H; Versteegh FG
Clin Infect Dis; 2009 Oct; 49(7):1086-9. PubMed ID: 19725791
[TBL] [Abstract][Full Text] [Related]
9. [Pertussis seroprevalence and vaccination status in three selected provinces of Turkey].
Kurtoğlu D; Gözalan A; Cöplü N; Miyamura K; Ishida S; Morita M; Akin L; Esen B
Mikrobiyol Bul; 2008 Jul; 42(3):389-98. PubMed ID: 18822881
[TBL] [Abstract][Full Text] [Related]
10. The relationship between pertussis symptomatology, incidence and serology in adolescents.
Cagney M; McIntyre PB; Heron L; Giammanco A; MacIntyre CR
Vaccine; 2008 Oct; 26(44):5547-53. PubMed ID: 18723066
[TBL] [Abstract][Full Text] [Related]
11. The seroepidemiology of immunoglobulin G antibodies against pertussis toxin in China: a cross sectional study.
Zhang Q; Zheng H; Liu M; Han K; Shu J; Wu C; Xu N; He Q; Luo H
BMC Infect Dis; 2012 Jun; 12():138. PubMed ID: 22892100
[TBL] [Abstract][Full Text] [Related]
12. Seroprevalence of IgG antibodies to pertussis toxin in children and adolescents in Estonia.
Jõgi P; Oona M; Toompere K; Leedo S; Epstein J; Lutsar I
Vaccine; 2014 Sep; 32(41):5311-5. PubMed ID: 25093282
[TBL] [Abstract][Full Text] [Related]
13. Impact of a pertussis booster vaccination program in adolescents and adults on the epidemiology of pertussis in Austria.
Rendi-Wagner P; Paulke-Korinek M; Stanek G; Khanakah G; Kollaritsch H
Pediatr Infect Dis J; 2007 Sep; 26(9):806-10. PubMed ID: 17721375
[TBL] [Abstract][Full Text] [Related]
14. Sero-epidemiology of Bordetella pertussis in England and Wales.
Nardone A; Pebody RG; Maple PA; Andrews N; Gay NJ; Miller E
Vaccine; 2004 Mar; 22(9-10):1314-9. PubMed ID: 15003661
[TBL] [Abstract][Full Text] [Related]
15. Bordetella pertussis and Bordetella parapertussis infection in an Austrian pediatric outpatient clinic.
Frühwirth M; Neher C; Schmidt-Schläpfer G; Allerberger F
Wien Klin Wochenschr; 2002 Jun; 114(10-11):377-82. PubMed ID: 12708090
[TBL] [Abstract][Full Text] [Related]
16. Survey of pertussis in patients with prolonged cough.
Hu JJ; Lu CY; Chang LY; Huang CH; Chou CC; Huang FY; Lee CY; Huang LM
J Microbiol Immunol Infect; 2006 Feb; 39(1):54-8. PubMed ID: 16440124
[TBL] [Abstract][Full Text] [Related]
17. Seroepidemiology of diphtheria and pertussis in Beijing, China: A cross-sectional study.
Li X; Chen M; Zhang T; Li J; Zeng Y; Lu L
Hum Vaccin Immunother; 2015; 11(10):2434-9. PubMed ID: 26177302
[TBL] [Abstract][Full Text] [Related]
18. Should fimbriae be included in pertussis vaccines? Studies on ELISA IgG anti-Fim2/3 antibodies after vaccination and infection.
Hallander HO; Ljungman M; Jahnmatz M; Storsaeter J; Nilsson L; Gustafsson L
APMIS; 2009 Sep; 117(9):660-71. PubMed ID: 19703126
[TBL] [Abstract][Full Text] [Related]
19. The 2001 serological survey in the Czech Republic--pertussis.
Maixnerová M
Cent Eur J Public Health; 2003 Dec; 11 Suppl():S17-22. PubMed ID: 15080254
[TBL] [Abstract][Full Text] [Related]
20. Antibody responses after vaccination and disease against leukocytosis promoting factor, filamentous hemagglutinin, lipopolysaccharide and a protein binding to complement-fixing antibodies induced during whooping cough.
Winsnes R; Lønnes T; Møgster B; Berdal BP
Dev Biol Stand; 1985; 61():353-65. PubMed ID: 2872124
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
